Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials

BACKGROUND: The clinical effect of bisphosphonate treatment has not been clearly evaluated by kidney function in Japanese Chronic Kidney Disease (CKD) patients with osteoporosis. This study analyzed the data from three risedronate Japanese phase III trials. The clinical effect of risedronate therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Takashi, Muraoka, Ryoichi, Sugimoto, Toshitsugu, Nishizawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311729/
https://www.ncbi.nlm.nih.gov/pubmed/28201994
http://dx.doi.org/10.1186/s12882-017-0478-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311729/
https://www.ncbi.nlm.nih.gov/pubmed/28201994
http://dx.doi.org/10.1186/s12882-017-0478-9

Ejemplares similares